These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5937786)

  • 1. The pharmaceutical treatment of gout.
    Kersley GD
    Ann Phys Med; 1966 May; 8(6):199-203. PubMed ID: 5937786
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of allopurinol, a xanthine oxidase inhibitor, and sulfinpyrazone upon the urinary and serum urate concentrations in eight patients with tophaceous gout.
    Goldfarb E; Smyth CJ
    Arthritis Rheum; 1966 Jun; 9(3):414-23. PubMed ID: 5938056
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of allopurinol in gout, hyperuricemia and uric acid lithiasis.
    Blechman WJ; Rosenberg DG; Hilf P
    South Med J; 1967 Feb; 60(2):215-8. PubMed ID: 6016656
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of gout.
    Goldfinger SE
    N Engl J Med; 1971 Dec; 285(23):1303-6. PubMed ID: 4941493
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of gout by reduction of uric acid production.
    Kersley GD
    Ann Rheum Dis; 1966 Jul; 25(4):353-5. PubMed ID: 5947580
    [No Abstract]   [Full Text] [Related]  

  • 6. Current therapy of gout and hyperuricemia.
    Kelley WN
    Hosp Pract; 1976 May; 11(5):69-76. PubMed ID: 1027698
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of gout.
    Wallace SL
    Arthritis Rheum; 1972; 15(3):317-23. PubMed ID: 5031616
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of gout.
    Kersley GD
    Scott Med J; 1973; 18():Suppl 1:249-50. PubMed ID: 4773968
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug control of gout and hyperuricaemia.
    Emmerson BT
    Drugs; 1978 Aug; 16(2):158-66. PubMed ID: 352666
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of the gout and other forms of crystal-induced arthritis.
    Rodnan GP
    Bull Rheum Dis; 1982; 32(5):43-53. PubMed ID: 6762236
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperuricemia and gout.
    Lo B
    West J Med; 1985 Jan; 142(1):104-7. PubMed ID: 3976216
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of gout.
    Simkin PA
    Ann Intern Med; 1979 May; 90(5):812-6. PubMed ID: 434690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal deposition joint disease.
    McCarty DJ
    Annu Rev Med; 1974; 25():279-88. PubMed ID: 4363208
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of the gouty diathesis with a xanthine oxidase inhibitor. A clinical trial of allopurinol].
    Nyfos L
    Ugeskr Laeger; 1967 Feb; 129(8):253-7. PubMed ID: 5599222
    [No Abstract]   [Full Text] [Related]  

  • 15. Etiology and treatment of gout--modern concepts.
    Riccitelli ML
    J Am Geriatr Soc; 1968 Jun; 16(6):719-28. PubMed ID: 5675393
    [No Abstract]   [Full Text] [Related]  

  • 16. [On gout].
    Schulze H
    Munch Med Wochenschr; 1966 Jan; 108(2):96-8. PubMed ID: 6013450
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs for gout.
    Med Lett Drugs Ther; 1976 Jun; 18(12):49-51. PubMed ID: 934016
    [No Abstract]   [Full Text] [Related]  

  • 18. Practical therapeutics treatment of gout.
    Obel AO
    East Afr Med J; 1981 Mar; 58(3):151-5. PubMed ID: 7249983
    [No Abstract]   [Full Text] [Related]  

  • 19. The management of gout.
    McCarty DJ
    Hosp Pract; 1979 Sep; 14(9):75-8, 83-5. PubMed ID: 478531
    [No Abstract]   [Full Text] [Related]  

  • 20. Uricosuric activity of suxibuzone, a new phenylbutazone derivative.
    Erill S; Laporte J
    Arch Farmacol Toxicol; 1975 Mar; 1(1):43-6. PubMed ID: 1231648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.